🇺🇸·8h agoResearch
Liposomal irinotecan (HR070803) plus fluorouracil and bevacizumab as second-line treatment in advanced colorectal cancer: Cohort A results from a phase 2 trial.
Publisher
A
ASCO JCO Journal
USA
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- ASCO JCO Journal
- Region
- USA
- Scope
- Research
- Published
- July 1, 2026
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on ascopubs.org
Leave the platform to read the original full article on the publisher site.
Source: ASCO JCO Journal
Scope: Research
Related coverage
More related coverage
Universitätsspital Zürich (USZ)/6h ago
Primäre Hirntumoren und Hirnmetastasen: neue Behandlungsansätze
Policlinico di Milano/7h ago
Oncologia, neurologia, infezioni e malattie infiammatorie: al Policlinico di Milano fabbrica hi-tech e radiofarmaci “in casa” per diagnosi rapide e cure personalizzate
UNMC/8h ago
A desire to make a difference: Dr. Davies becomes UNMC chancellor
ASCO JCO Journal/8h ago